Winthrop Partners - WNY’s AbbVie ABBV Stock Holding History

Winthrop Partners - WNY’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Buy	5,801 +82	+1%	+$17.6K	0.72%	38
2026 Q1	$1.24M	Sell	5,719 -47	-0.8%	-$10.4K	0.66%	40
2025 Q4	$1.32M	Buy	+5,766	New	+$1.31M	0.71%	37
2019 Q3	$37.9K	Sell	500 -500	-50%	-$34.3K	0.03%	185
2019 Q2	$72.7K	Sell	1,000 -6,089	-86%	-$479K	0.05%	139
2019 Q1	$573K	Buy	7,089 +2,199	+45%	+$180K	0.45%	63
2018 Q4	$451K	Sell	4,890 -290	-6%	-$25.5K	0.42%	61
2018 Q3	$490K	Buy	5,180 +1,362	+36%	+$129K	0.4%	68
2018 Q2	$354K	Buy	3,818 +332	+10%	+$32.4K	0.29%	82
2018 Q1	$315K	Buy	3,486 +143	+4%	+$15.7K	0.24%	92
2017 Q4	$399K	Buy	+3,343	New	+$315K	0.33%	83

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Winthrop Partners - WNY's ABBV Position: Q2 2026 in Review

Winthrop Partners - WNY increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $17.6K and bringing the position to 5,801 shares worth $1.46M. The position accounts for 0.72% of the portfolio, ranked #38.

Winthrop Partners - WNY first reported a position in ABBV in Q4 2017 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Winthrop Partners - WNY held 5,801 shares of AbbVie worth $1.46M as of Q2 2026.
Winthrop Partners - WNY bought 82 AbbVie shares in Q2 2026, an estimated $17.6K.
AbbVie made up 0.72% of Winthrop Partners - WNY's portfolio in Q2 2026, its #38 holding.
Winthrop Partners - WNY first reported a position in AbbVie in Q4 2017 and has held it in 11 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Winthrop Partners - WNY's 13F filing for Q2 2026, filed 15 Jul 2026.